Outcomes of Refractory Cytomegalovirus Infection in the First Year after Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Outcomes of Refractory Cytomegalovirus Infection in the First Year after Allogeneic Hematopoietic Cell Transplantation

Published:2022-07 Issue:7 Volume:28 Page:403.e1-403.e7
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Karantoni Eleni^ORCID,Zavras Phaedon D.^ORCID,Su Yiqi,Fang Jiaqi,Tamari Roni,Cho Christina,Perales Miguel-Angel,Stern Anat^ORCID,Papanicolaou Genovefa A.^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference31 articles.

1. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis;Teira;Blood,2016

2. Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study;Green;Lancet Haematol,2016

3. Cytomegalovirus viral load kinetics predict cytomegalovirus end-organ disease and mortality after hematopoietic cell transplant;Stern;J Infect Dis,2021

4. Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory cytomegalovirus infection;Avery;Transplantation,2016

5. Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials;Chemaly;Clin Infect Dis,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation;Antiviral Therapy;2023-09-01

2. Management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplants;International Journal of Antimicrobial Agents;2023-08

3. Maribavir versus investigator assigned therapy: Exploring the exploratory;Transplant Infectious Disease;2023-04-13

4. Maribavir for the Management of Cytomegalovirus in Adult Transplant Recipients: A Review of the Literature and Practical Considerations;Annals of Pharmacotherapy;2022-08-24